Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length

Bioorg Med Chem Lett. 2010 Feb 1;20(3):997-9. doi: 10.1016/j.bmcl.2009.12.054. Epub 2009 Dec 21.

Abstract

Bicyclic tetrapeptide hydroxamic acids were prepared as histone deacetylase (HDAC) inhibitors, and the evaluated inhibitory activity shows that they are potent against HDAC1 and HDAC4. The in vivo activity depends on alkyl loop length.

Publication types

  • Comparative Study

MeSH terms

  • Bridged Bicyclo Compounds / chemical synthesis
  • Bridged Bicyclo Compounds / metabolism
  • Bridged Bicyclo Compounds / pharmacology
  • Histone Deacetylase Inhibitors / chemical synthesis*
  • Histone Deacetylase Inhibitors / metabolism
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases / chemistry
  • Histone Deacetylases / metabolism*
  • Hydroxamic Acids / chemical synthesis*
  • Hydroxamic Acids / metabolism
  • Hydroxamic Acids / pharmacology
  • Oligopeptides / chemical synthesis*
  • Oligopeptides / metabolism
  • Oligopeptides / pharmacology

Substances

  • Bridged Bicyclo Compounds
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Oligopeptides
  • Histone Deacetylases